Source link : https://newshealth.biz/health-news/immediately-practice-changing-trial-in-small-cell-lung-cancer/
(MedPage Today) — CHICAGO — The bispecific T-cell engager tarlatamab (Imdelltra) significantly prolonged survival in the second-line treatment of small cell lung cancer (SCLC), a practice-changing phase III trial showed. In patients whose… Source link : https://www.medpagetoday.com/meetingcoverage/asco/115891 Author : Publish date : 2025-06-03 21:16:00 Copyright for syndicated content belongs to the linked Source.
The post ‘Immediately Practice-Changing’ Trial in Small Cell Lung Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-03 21:16:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8